Cronos price to sales ratio CRON

Market value divided by revenue over the last twelve months, since 2020.

Today, Oct 23, 2026: 6.9×
7-year median: 9.6×
Against its 7-year history: 19th; percentile: 0 is its lowest day, 100 its highest
7-year range: 5.6× to 118×
Peer median: 2.4×

Cronos' price to sales ratio is 6.9× as of Oct 23, 2026.

That is below its 7-year median of 9.6×, lower than on 81% of days in the last 7 years.

Over that time it ranged from 5.6× in Apr 2025 to 118× in Feb 2021.

The median for 10 chemicals stocks of a similar size is 2.4×.

Price to sales ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	6.9×	6.2×	8.0×
2025	7.7×	5.6×	9.5×
2024	6.8×	6.6×	11.9×
2023	9.2×	7.3×	11.0×
2022	10.1×	10.1×	26.5×
2021	25.7×	25.7×	118×
2020	66.8×	56.0×	91.1×

Against its peers

Companies in Chemicals nearest Cronos' size, closest first, today.

Company	Price to sales ratio
CRONCronos	6.9×
FTKFlotek Industries	3.0×
ROGRogers	2.7×
NGVTIngevity	2.1×
IOSPInnospec	1.3×
FULFuller H B	0.8×
WDFCWD 40	4.2×
AVNTAvient	1.1×
CBTCabot	1.0×
CSWCSW Industrials	4.1×
BCPCBalchem	5.2×
Peer median	2.4×

Where Cronos ranks

#39of 43Chemicals stocks with the lowest price to sales ratio

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on Cronos

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.